MBX Biosciences has rallied more than 230% over the past year, but there’s room for still more upside from current levels, according to UBS.
After Circle’s ARC token reveal, even cautious analysts are hiking price targets for the stablecoin stock
ARC will be the native token of Circle’s homegrown Arc blockchain, which is designed for AI-driven financial activity.
Small investors are piling into this ETF at a record pace. What the frenzy is all about
The memory chip shortage is suddenly making one ETF a go-to for retail traders.
This chocolate stock is beginning to turn around after steep two-month slide. How to capitalize on it
Nishant Pant walks readers through this bull call spread.
Buy this drone stock as demand for unmanned aircrafts grows, Goldman Sachs says
The bank initiated coverage of the drone name with a buy rating.
AI super rally has retail investors acting the most aggressive since trading frenzy during Covid
Retail traders are buying calls in Cboe’s “Mag 10” stocks – the big seven plus AMD, Palantir and Broadcom – at the heaviest 10-day clip since 2021, according to a report from the exchange.
This home improvement stock has lagged in 2026. Citi says it’s time to buy
Lowe’s, which is trading at a discount, is likely to see its shares rise as it continues to clock strong same store sales despite economic concerns, per Citi.
AI will drive Nvidia higher by more than 40% from here, says Wells Fargo
The bank, which has an overweight rating on the chipmaker, raised its price target on the stock.
Tuesday’s big stock stories: What’s likely to move the market in the next trading session
Investors looked past another setback in the Middle East on Monday, as the S&P 500 ticked higher for its first close above 7,400.
Investors are piling into dividend stocks this year. These names top Wall Street’s buy list
CNBC Pro screened for dividend-paying stocks that have an average rating of buy and at least 15% upside to the average price target.